STOCK TITAN

Intellia (NTLA) director Muna Bhanji granted 9,200 RSUs and 13,300 options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Intellia Therapeutics director Muna Bhanji received new equity awards. She was granted 9,200 shares of common stock based on restricted stock units, bringing her direct common stock holdings to 36,403 shares.

She was also granted stock options for 13,300 shares at an exercise price of $12.89 per share. These options vest in full on the earlier of the first anniversary of the June 9, 2026 grant date or the next annual meeting of stockholders, and expire on June 8, 2036.

Positive

  • None.

Negative

  • None.
Insider Bhanji Muna
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 13,300 $0.00 --
Grant/Award Common Stock 9,200 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 13,300 shares (Direct); Common Stock — 36,403 shares (Direct)
Footnotes (1)
  1. Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
RSU-based common shares granted 9,200 shares Grant of restricted stock units on June 9, 2026
Common stock held after grant 36,403 shares Total direct common stock holdings following RSU grant
Stock options granted 13,300 options New stock option award on June 9, 2026
Option exercise price $12.89 per share Exercise price for 13,300 stock options
Option expiration date June 8, 2036 Expiration for 13,300 stock options
restricted stock units financial
"Based on a grant of restricted stock units representing a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option financial
"This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vests in full financial
"vests in full on the earlier to occur of (a) the first anniversary of the grant date"
annual meeting of stockholders financial
"or (b) the date of the next annual meeting of stockholders following the date of grant"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Intellia Therapeutics (NTLA) director Muna Bhanji receive in this Form 4?

Muna Bhanji received equity compensation consisting of 9,200 restricted stock unit-based common shares and 13,300 stock options. These are compensation grants, not open-market purchases or sales, and increase her direct ownership stake in Intellia Therapeutics.

How many Intellia Therapeutics (NTLA) shares does Muna Bhanji hold after this grant?

After the grant, Muna Bhanji directly holds 36,403 shares of Intellia common stock. This reflects the addition of 9,200 shares tied to restricted stock units granted on June 9, 2026, as reported in the Form 4 filing.

What are the terms of Muna Bhanji’s new Intellia (NTLA) stock options?

She was granted options for 13,300 shares of Intellia common stock at a $12.89 exercise price. The options vest in full on the earlier of the first anniversary of the June 9, 2026 grant or the next annual stockholder meeting, and expire June 8, 2036.

Is the Intellia (NTLA) Form 4 for Muna Bhanji a stock purchase or compensation grant?

The Form 4 reflects compensation grants, not market purchases. It reports an award of 9,200 restricted stock unit-based shares and 13,300 stock options, both coded as grants or awards rather than open-market buying or selling activity.

How are the restricted stock units described in the Intellia (NTLA) Form 4 footnotes?

The footnotes state the award is based on restricted stock units representing a contingent right to receive one share of Intellia common stock for each unit. This clarifies the 9,200-share grant is tied to RSUs rather than an immediate cash purchase.

When do Muna Bhanji’s new Intellia (NTLA) options fully vest?

The options vest in full on the earlier of two dates: the first anniversary of the June 9, 2026 grant date, or the date of the next annual meeting of stockholders following that grant. After vesting, she may exercise them until June 8, 2036.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bhanji Muna

(Last)(First)(Middle)
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET; SUITE 130

(Street)
CAMBRIDGE MASSACHUSETTS 02139

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Intellia Therapeutics, Inc. [ NTLA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)06/09/2026A9,200A$0.0036,403D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$12.8906/09/2026A13,300 (2)06/08/2036Common Stock13,300$0.0013,300D
Explanation of Responses:
1. Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
2. This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
James Basta, attorney-in-fact06/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)